- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Potentially Undervalued Companies
Australian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
41
Companies with a Value score of at least 3, ordered by Value score
41 companies
Trajan Group Holdings
Market Cap: AU$131.0m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.81
7D
3.8%
1Y
-34.7%
Aroa Biosurgery
Market Cap: AU$134.5m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.40
7D
5.3%
1Y
-28.2%
Aroa Biosurgery
Market Cap: AU$134.5m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.44
7D
17.3%
1Y
-20.0%
Trajan Group Holdings
Market Cap: AU$131.0m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.75
7D
1.4%
1Y
-39.0%
EZZ Life Science Holdings
Market Cap: AU$68.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.41
7D
-4.4%
1Y
77.8%
Medical Developments International
Market Cap: AU$56.3m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.49
7D
10.0%
1Y
-13.9%
Little Green Pharma
Market Cap: AU$36.3m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.13
7D
4.2%
1Y
-10.7%
CSL
Market Cap: AU$112.9b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$233.47
7D
-9.0%
1Y
-17.2%
AVITA Medical
Market Cap: AU$227.9m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
AVH
AU$2.75
7D
15.1%
1Y
-18.4%
Little Green Pharma
Market Cap: AU$36.3m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.12
7D
9.1%
1Y
-14.3%
Neuren Pharmaceuticals
Market Cap: AU$1.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$11.13
7D
23.0%
1Y
-45.4%
Medical Developments International
Market Cap: AU$56.3m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.48
7D
3.2%
1Y
-16.5%
AVITA Medical
Market Cap: AU$227.9m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
AVH
AU$2.78
7D
14.9%
1Y
-11.5%
Neuren Pharmaceuticals
Market Cap: AU$1.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$9.17
7D
-6.5%
1Y
-55.8%
EZZ Life Science Holdings
Market Cap: AU$68.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.45
7D
10.7%
1Y
70.6%
Mesoblast
Market Cap: AU$2.0b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.57
7D
-11.3%
1Y
83.0%
Clinuvel Pharmaceuticals
Market Cap: AU$529.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.74
7D
5.7%
1Y
-29.3%
Radiopharm Theranostics
Market Cap: AU$53.7m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.022
7D
15.8%
1Y
-53.2%
Mayne Pharma Group
Market Cap: AU$305.4m
A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
MYXDA
AU$3.47
7D
-9.4%
1Y
n/a
Biotron
Market Cap: AU$3.3m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
-14.3%
1Y
-96.1%
CSL
Market Cap: AU$112.9b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$238.00
7D
-1.6%
1Y
-14.6%
Radiopharm Theranostics
Market Cap: AU$53.7m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.023
7D
21.1%
1Y
-50.0%
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.1m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.039
7D
0%
1Y
-36.1%
Biotron
Market Cap: AU$3.3m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
-25.0%
1Y
-95.9%
Clinuvel Pharmaceuticals
Market Cap: AU$529.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.61
7D
4.5%
1Y
-29.7%
Genetic Signatures
Market Cap: AU$85.2m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.39
7D
-12.5%
1Y
-44.6%
Mayne Pharma Group
Market Cap: AU$305.4m
A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
MYXDA
AU$3.54
7D
-9.2%
1Y
n/a
Genetic Signatures
Market Cap: AU$85.2m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.38
7D
-24.2%
1Y
-44.0%
Mesoblast
Market Cap: AU$2.0b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.66
7D
2.8%
1Y
100.0%
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.1m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.035
7D
0%
1Y
-42.6%
PYC Therapeutics
Market Cap: AU$539.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$0.98
7D
-10.5%
1Y
2.1%
Telix Pharmaceuticals
Market Cap: AU$8.8b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.
TLX
AU$26.18
7D
9.9%
1Y
102.5%
Cryosite
Market Cap: AU$38.8m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.80
7D
5.3%
1Y
15.2%
Immuron
Market Cap: AU$15.6m
A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.
IMC
AU$0.066
7D
2.3%
1Y
-40.0%
Cynata Therapeutics
Market Cap: AU$42.9m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.18
7D
23.3%
1Y
-9.8%
Cryosite
Market Cap: AU$38.8m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.80
7D
0%
1Y
n/a